OLFACTION AND BIPOLAR DISODER

To compare olfactory performance between patients with BD and HC and correlate their performances to neuroimaging data

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Bipolar Disorder Bipolar and Related Disorders Mental Disorders Mood Disorders

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Inserm U 955 Eq 15

Créteil, VAL DE MARNE, 94000, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with BD and HC
Fluent in french
Having a public health insurance
Not being on tutorship

Exclusion criteria

Family history of bipolar disorder for controls
Alcohol dependence

Treatment and study plan

olfactory testing, MRI acquisition, clinical assessment

Other

Primary outcomes

Olfactive performance

Time frame: through study completion, an average of 4 years

Testing of olfactory performance (odor threshold, odor discrimination, odor identification)

Sponsors and collaborators

Lead sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Other Gov

Registry information

Acronym: OLF-BP

Important dates

Study start: 2016
Primary completion: 2020
Study completion: 2020
First posted: Feb 5, 2025
Registry last updated: Sep 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed